Optical Coherence Tomography (OCT): 60 Second Insights
Published: 08 March 2018
-
Views:
8
-
Likes:
7
-
Views:
8
-
Likes:
7
-
Up Next -
Part 1 | Session 2 Gary Mintz
-
Part 1 | Session 3 Rajesh Kharbanda
-
Part 2 | Session 1 Michael Joner
-
Part 2 | Session 2 Gary Mintz
-
Part 2 | Session 3 Rajesh Kharbanda
-
Part 3 | Session 1 Michael Joner
-
Part 3 | Session 2 Gary Mintz
-
Part 3 | Session 3 Rajesh Kharbanda
-
Part 4 | Session 1 Michael Joner
-
Part 4 | Session 2 Gary Mintz
-
Part 4 | Session 3 Rajesh Kharbanda
-
Part 5 | Session 1 Michael Joner
-
Part 5 | Session 2 Gary Mintz
-
Part 5 | Session 3 Rajesh Kharbanda
-
Part 6 | Session 1 Michael Joner
-
Part 6 | Session 2 Gary Mintz
-
Part 6 | Session 3 Rajesh Kharbanda
-
Part 7 | Session 1 Michael Joner
-
Part 7 | Session 2 Gary Mintz
-
Part 7 | Session 3 Rajesh Kharbanda
-
Part 8 | Session 1 Michael Joner
-
Part 8 | Session 2 Gary Mintz
-
Part 8 | Session 3 Rajesh Kharbanda
Overview
A short series of 60-second insight videos on Optical Coherence Tomography (OCT). Hear the expert views in under one minute!
More from this programme
Part 1
Do you think the role of OCT has diminished following the withdrawal of BVS?
Part 2
What tips would you give for administering contrast?
Part 3
What is the most important trial to support the use of OCT?
Part 4
What disadvantages do you think OCT offers over other imaging modalities?
Part 5
What cases would you use OCT in?
Part 6
What cases would you not use OCT in?
Part 7
What advantages do you think OCT offers over other imaging modalities?
Part 8
Should we trust dimensions from OCT or IVUS, and why?
Faculty Biographies
Michael Joner
Head, Preclinical Research
Dr Michael Joner MD is the head, preclinical research, German Heart Centre, Munich and CEO, CVPath Institute, Gaithersburg, MaryLand. He completed his medical training at the University of Wuerzburg and spent 2004-2006 as a cardiovascular pathology fellow at the CVPath Institute. After returning to Germany, since 2007 Dr. Joner has been Head of the Preclinical Research at the German Heart Center in Munich, where he also completed his interventional cardiology residency.